RegistriesTissue DonorsBlood DonorsLiving DonorsIncidenceTreatment OutcomeRisk FactorsTissue and Organ ProcurementTime FactorsRetrospective StudiesUnited StatesFollow-Up StudiesGraft SurvivalProspective StudiesKidney TransplantationTransplantation, HomologousCohort StudiesAge FactorsDenmarkLiver TransplantationSurvival RateRisk AssessmentNeoplasmsSEER ProgramSurvival AnalysisHistocompatibility TestingInfant, NewbornEuropeAge DistributionBone Marrow TransplantationTissue and Organ HarvestingHospital MortalityDatabases, FactualPrognosisNorwayProportional Hazards ModelsPatient SelectionRare DiseasesGraft RejectionSwedenMultivariate AnalysisCadaverAngioplasty, Balloon, CoronaryLogistic ModelsGraft vs Host DiseaseMyocardial InfarctionKaplan-Meier EstimateSex FactorsPopulation SurveillanceBrain DeathMedical Record LinkageGermanyItalyHistocompatibilityPostoperative ComplicationsFranceOdds RatioSex DistributionDrug-Eluting StentsBreast NeoplasmsCause of DeathHematopoietic Stem Cell TransplantationChi-Square DistributionRiskHospital RecordsDiseases in TwinsPrevalenceInsemination, Artificial, HeterologousJapanRecurrenceCase-Control StudiesSpainStrokePregnancyHeart TransplantationData CollectionAustraliaOocyte DonationWaiting ListsStentsHLA AntigensHospitalizationQuestionnairesTwins, MonozygoticMedical RecordsCaliforniaDeathBlood BanksSeverity of Illness IndexOrgan TransplantationComorbidityImmunosuppressive AgentsResearch DesignOutcome Assessment (Health Care)Blood TransfusionTwins, DizygoticCongenital AbnormalitiesDirected Tissue DonationTransplantsCanada